Clinical Trials Logo

Clinical Trial Summary

Epo increases red blood cell production and hence the amount of oxygen that can be transported around the body. It is shown that prolonged use of synthetic Epo (rHuEpo) leads to an increase in the period of time a given physical work can be performed, therefore it will continue to be abused by athletes, especially in endurance sports.

The existing method for measuring the abuse of rHuEpo approved by the World Anti-Doping Agency (WADA) is based on differences in the sugar groups bound to rHuEpo and Epo produced in the body, respectively.

Proteomics is a method by which one can look at all the proteins in blood at the same time. Even proteins that have changed very little can be distinguished. The main objective of this project is to investigate the effect of prolonged treatment with rHuEpo on changes in blood proteins in healthy young men.


Clinical Trial Description

n/a


Study Design

Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Single Blind (Subject), Primary Purpose: Basic Science


Related Conditions & MeSH terms


NCT number NCT01320449
Study type Interventional
Source University of Aarhus
Contact
Status Completed
Phase N/A
Start date August 2011
Completion date July 2012

See also
  Status Clinical Trial Phase
Completed NCT02740881 - Web-Based Contingency Management Training for Addictions N/A
Completed NCT02872467 - Prenatal Cocaine, Nasal Oxytocin, and Maternal Psychophysiology Phase 1
Completed NCT00249613 - Gender-Responsive Treatment for Women Offenders - 1 N/A
Completed NCT02715206 - Adaptation Processes in School-based Substance Abuse Prevention N/A
Active, not recruiting NCT02213614 - Lithium Water in Gun Violence Prevention N/A
Recruiting NCT01812187 - Designing a Mobile App for Veterans With Substance Use Problems N/A